TREA

79222695 - R&D BIONICE

Follow

Information

  • Trademark
  • 79222695
  • Serial Number
    79222695
  • Filing Date
    April 17, 2017
    7 years ago
  • Transaction Date
    February 12, 2021
    3 years ago
  • Status Date
    August 06, 2018
    6 years ago
  • Location Date
    August 06, 2018
    6 years ago
  • Status Code
    602
  • Current Location
    LAW OFFICE 117 - EXAMINING ATTORNEY ASSIGNED
    Employee Name
    SAUNDERS, ANDREA DAWN
  • Law Office Assigned Location Code
    M80
  • Owners
Information
Mark Drawing Code
3000
Mark Identification
R&D BIONICE
Case File Statements
  • CC0000: The color(s) blue and gray is/are claimed as a feature of the mark.
  • CD0000: It consists in the designation "R&D BioNice". The letters "R&D" and "Bio" are represented in blue, while "Nice" appears in gray.
  • GS0051: Pharmaceutical and veterinary active ingredients for treating diseases of the alimentary tract and metabolism; pharmaceutical and veterinary active ingredients for treating diseases of the cardiovascular system; pharmaceutical and veterinary active ingredients for treatment of diseases of the skin; pharmaceutical and veterinary active ingredients for treatment of diseases of the respiratory system; pharmaceutical and veterinary active ingredients for treating diseases of the musculoskeletal system; pharmaceutical and veterinary active ingredients for treating diseases of the nervous system; pharmaceutical preparations, namely, antidepressants; sanitary products for medical use; dietetic food and substances for medical or veterinary use; disinfectants; products for destroying vermin; fungicides, herbicides; chemical preparations for pharmaceutical and veterinary use, namely, for treating diseases of the cardiovascular, respiratory, musculoskeletal and the nervous system; hormones for medical use; steroids; antihistamines
  • GS0401: Custom manufacture of pharmaceutical and veterinary active ingredients for treating diseases of the alimentary tract and metabolism, diseases of the cardiovascular system, diseases of the skin, diseases of the respiratory system, diseases of the musculoskeletal system and diseases of the nervous system; custom manufacture of chemico-pharmaceutical preparations, namely, antidepressants; custom manufacture of sanitary products for medical use; custom manufacture of dietetic food and substances for medical or veterinary use; custom manufacture of disinfectants, products for destroying vermin, fungicides and herbicides; custom manufacture of chemical preparations for pharmaceutical and veterinary use, namely, for treating diseases of the cardiovascular, respiratory, musculoskeletal and the nervous system; custom manufacture of hormones for medical use, steroids and antihistamines; processing of pharmaceutical and chemical products
  • GS0421: Pharmaceutical research and development; providing medical research information; providing veterinary research information; conducting clinical trials for others relating to pharmaceutical products; laboratory services, namely, analytical laboratory services; analysis and evaluation of product development; design and development of new technology for others in the field of biotechnology, pharmacy and chemistry; provision of information, advice and consultancy relating to all the aforementioned services
Case File Event Statements
  • 2/12/2021 - 3 years ago
    20 - CHANGE OF OWNER RECEIVED FROM IB Type: CHLD
  • 8/23/2019 - 5 years ago
    19 - FINAL DECISION TRANSACTION PROCESSED BY IB Type: FINT
  • 8/6/2019 - 5 years ago
    18 - FINAL DISPOSITION NOTICE SENT TO IB Type: FICS
  • 8/6/2019 - 5 years ago
    17 - FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Type: FICR
  • 5/24/2019 - 5 years ago
    16 - NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB Type: OPNX
  • 5/23/2019 - 5 years ago
    15 - NEW REPRESENTATIVE AT IB RECEIVED Type: NREP
  • 5/8/2019 - 5 years ago
    14 - NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Type: OPNS
  • 5/8/2019 - 5 years ago
    13 - NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB Type: OPNR
  • 8/6/2018 - 6 years ago
    12 - ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND Type: MAB2
  • 8/6/2018 - 6 years ago
    11 - ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE Type: ABN2
  • 1/27/2018 - 6 years ago
    10 - REFUSAL PROCESSED BY IB Type: RFNT
  • 1/6/2018 - 7 years ago
    9 - NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Type: RFCS
  • 1/6/2018 - 7 years ago
    8 - REFUSAL PROCESSED BY MPU Type: RFRR
  • 12/19/2017 - 7 years ago
    7 - APPLICATION FILING RECEIPT MAILED Type: MAFR
  • 12/16/2017 - 7 years ago
    6 - NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Type: RFCR
  • 12/15/2017 - 7 years ago
    5 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 12/15/2017 - 7 years ago
    4 - ASSIGNED TO EXAMINER Type: DOCK
  • 12/15/2017 - 7 years ago
    3 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM Type: NWOS
  • 12/13/2017 - 7 years ago
    2 - LIMITATION FROM ORIGINAL APPLICATION ENTERED Type: LIMI
  • 12/7/2017 - 7 years ago
    1 - SN ASSIGNED FOR SECT 66A APPL FROM IB Type: REPR